Company Highlights

2026/06/16

Integrated Nanotherapeutics is featured by Pacific Economic Development Canada (PacifiCan) with an exclusive interview with our CEO, Chris Tam.

2026/06/10

Integrated Nanotherapeutics will be partnering at BIO International 2026, June 22-25, in San Diego, CA.

2026/05/06

Integrated Nanotherapeutics will be exhibiting at Web Summit 2026, May 11-14, in Vancouver, BC.

2026/04/20

Integrated Nanotherapeutics will be speaking at the 21st Immunology of Diabetes Society Congress & Australian Islet Study Group Meeting (IDS) 2026, Apr 20-24, in Brisbane, Australia.

2026/03/18

Integrated Nanotherapeutics Secures Genome Canada GAPP Funding to Advance Multi-Cargo mRNA/LNP Therapy for Type 1 Diabetes Toward the Clinic.

2026/03/03

Integrated Nanotherapeutics will be speaking at the 9th Antigen-Specific Immune Tolerance Summit (ASIT) 2026 Annual Meeting, Mar 3-6, in Boston.

2026/01/12

Integrated Nanotherapeutics will be attending Biotech Showcase 2026 during JPM Week, Jan 13 – 15, in San Francisco.

2025/02/25

Integrated Nanotherapeutics will be speaking at the 8th Antigen-Specific Immune Tolerance Summit (ASIT) 2025, Feb 25 – 27, in Boston.

2025/01/13

Integrated Nanotherapeutics will be attending Biotech Showcase 2025 during JPM Week, Jan 13 – 15, in San Francisco.

2024/09/09

Integrated Nanotherapeutics and Breakthrough T1D Collaborate to Advance Development of an Immune Tolerizing Therapeutic to Treat Type 1 Diabetes.

2024/06/11

Integrated Nanotherapeutics is presenting T1D preclinical data at the Federation of Clinical Immunology Societies (FOCIS) 2024 Annual Meeting, June 18 – 21, in San Francisco.

2026/06/18

Integrated Nanotherapeutics welcomes Dr. Carmella Evans-Molina to the Scientific Advisory Board.

2026/06/22

Integrated Nanotherapeutics was invited to exhibit at World Health Expo (WHX) Osaka 2026, July 2-4, in Osaka, Japan.

2026/09/08

Integrated Nanotherapeutics will be partnering at RESI Boston 2026, Sept 22-23, in Boston, MA.

2026/09/10

Integrated Nanotherapeutics receives an award as one of Life Sciences BC 2026 “Companies to Watch”.

2026/10/01

Integrated Nanotherapeutics is presenting at Breakthrough T1D Clinical & Research Congress 2026, October 9-11, in Philadelphia, PA.